3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
5
Thoracic
2
Gastrointestinal
2
Head & Neck
1
Gynecologic
1
Dermatologic
1
Breast
1
Conditions
Ovarian Neoplasms
24
Uterine Cervical Neoplasms
18
Fallopian Tube Neoplasms
15
Endometrial Neoplasms
13
Neoplasm Metastasis
9
Breast Neoplasms
9
Pancreatic Neoplasms
8
Uterine Cervical Dysplasia
6
Melanoma
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Stomach Neoplasms
4
Precancerous Conditions
4
Carcinosarcoma
4
Carcinoma, Renal Cell
4
Vulvar Neoplasms
3
Uterine Neoplasms
3
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Squamous Intraepithelial Lesions
3
Sarcoma
3
Salivary Gland Neoplasms
3
Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Carcinoma, Non-Small-Cell Lung
3
Anus Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Rectal Neoplasms
2
Papillomavirus Infections
2
Interventions
pembrolizumab
10
Filgrastim
7
Ifosfamide
4
Carboplatin
4
aldesleukin
3
Temozolomide
3
Peripheral Blood Stem Cell Transplantation
3
Drug Therapy
3
Docetaxel
3
Cyclophosphamide
3
Counseling
3
fludarabine phosphate
2
fludarabine
2
etoposide phosphate
2
cemiplimab
2
belinostat
2
atezolizumab
2
Thiotepa
2
Surveys and Questionnaires
2
Radiotherapy
2
Nivolumab
2
Methods
2
Metformin
2
Early Intervention, Educational
2
Doxorubicin
2
Bupropion
2
Blood Specimen Collection
2
Amifostine
2
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol
2
valspodar
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Biopsy
×
Gynecologic
×
Clear all
NCT07327489
2026-01-08
ELEPHAS-05
Elephas
Recruiting
2,000 enrolled